NKILT Therapeutics is a new cell therapy biotech in stealth mode, that is developing a novel approach of targeting NK cells to fight hard to treat leukemias and solid tumors. Our platform will be based on an allogeneic approach using armored NK cells, focused on a new undisclosed target. Our NK cells will not only directly kill cancer cells, but will also activate innate immunity and directly target the tumor's defense mechanisms.